| Financial Year |
March 31 2023 |
| Monetary Funds |
5,567,105,525.63 |
| Held-for-trading Financial Assets |
129,439,553.55 |
| Notes Receivable |
12,406,438.27 |
| Accounts Receivable |
590,928,359.84 |
| Advances to Suppliers |
961,631,666.73 |
| Other Receivables |
7,597,736,088.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
29,758,343,780.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,255,381,661.37 |
| Other Current Assets |
1,576,896,391.94 |
| Total Current Assets |
47,499,641,641.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,197,793,302.24 |
| Long-term Equity Investment |
4,023,502,115.86 |
| Investment Properties |
2,952,710,688.93 |
| Fixed Assetes |
4,680,530,799.31 |
| Under-construction Projects |
2,359,121,600.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,574,426,300.02 |
| R&D expenses |
-- |
| Goodwill |
94,240,965.55 |
| Long-Term Deferred and Prepaid Expenses |
103,389,343.25 |
| Deferred Income Tax Assets |
440,216,391.61 |
| Other Non-Current Assets |
7,340,139.76 |
| Sub-Total of Non-Current Assets |
18,865,945,112.09 |
| Total Assets |
66,365,586,754.06 |
| Short-Term Loans |
15,914,575.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
149,354,351.41 |
| Accounts Payable |
3,936,946,702.34 |
| Accounts Received In Advance |
51,073,651.23 |
| Employee Compensation Payable |
49,966,363.85 |
| Taxes Payable |
182,532,506.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,715,972,656.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,439,770,728.42 |
| Other Current Liabilities |
515,540,001.30 |
| Sub-Total of Current Liabilities |
18,655,566,371.95 |
| Long-term Loans |
22,629,733,742.27 |
| Bonds Payable |
7,805,725,926.35 |
| Long-Term Accounts Payable |
12,799,900.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
30,294,158.79 |
| Deferred Income Tax Liabilities |
222,543,181.69 |
| Other Non-Current Liabilities |
1,942,085.51 |
| Sub-Total of Non-Current Liabilities |
30,972,960,229.95 |
| Total Liabilities |
49,628,526,601.90 |
| Paid-In Capital(Or Share Stock) |
1,151,292,907.00 |
| Capital Surplus |
1,632,211,111.19 |
| Surplus Reserve |
471,564,501.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,623,558,373.10 |
| Minority Stockholder's Interest |
7,456,352,538.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,280,707,613.22 |
| Owner's Equity（Stockholder's Equity） |
16,737,060,152.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
66,365,586,754.06 |
